TY - JOUR T1 - HPV vaccine: positive insights from universal adolescent HepB vaccination JF - Journal of Epidemiology and Community Health JO - J Epidemiol Community Health SP - 1018 LP - 1019 DO - 10.1136/jech.2007.059832 VL - 61 IS - 12 AU - J Claire Cameron AU - Lesley A Wallace AU - Syed Ahmed AU - Rina Duff AU - Martin Donaghy AU - David J Goldberg Y1 - 2007/12/01 UR - http://jech.bmj.com/content/61/12/1018.abstract N2 - The introduction of universal adolescent HPV vaccination in schools has a positive outlookPreventing cervical cancer by vaccination has become a reality, complementing highly successful screening programmes. One vaccine against human papillomavirus (HPV) is already licensed (Gardasil®, Sanofi Pasteur), and approval for a second (Cervarix®, GSK) is expected shortly. Trials indicate over 90% efficacy in preventing persistent infection with vaccine types (HPV-16 and 18).1 2 In several countries, including the United States, Canada, Australia, Austria, Italy, Germany and France, HPV vaccination has now been universally recommended. Other countries, including the UK, are considering recommendations for its use.The clinical benefit of HPV vaccines is incontrovertible, and excellent safety profiles have been established. As HPV is a sexually transmitted infection, however, some groups are anxious that vaccination may encourage earlier sexual activity.3 Further, uncertainty about the programme’s optimal delivery setting remains.3However, precedents exist. First, with rubella, against which many countries vaccinated adolescent schoolgirls to protect during later pregnancy, and more recently with hepatitis B (HepB), against which some countries, including Italy, Spain and France, have had universal … ER -